[Nephrogenous diabetes insipidus secondary to the administration of amphotericin B and liposomal amphotericin B].
Araujo
J J
JJ
Domínguez
A
A
Bueno
C
C
Rodríguez
J
J
Ríos
M J
MJ
Muniain
M A
MA
Pérez
R
R
D000328:Adult; D000666:Amphotericin B / Q000009:adverse effects*; D000935:Antifungal Agents / Q000009:adverse effects*; D003919:Diabetes Insipidus / Q000139:chemically induced*; D003928:Diabetic Nephropathies / Q000139:chemically induced*; D006801:Humans; D008081:Liposomes; D008297:Male
D000935:Antifungal Agents; D008081:Liposomes; C068538:liposomal amphotericin B; D000666:Amphotericin B
Diabetes insípida nefrogénica secundaria a la administración de anfotericina B y anfotericina B liposomal.